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Abstract
P2X receptors are expressed on different functional groups of primary afferent fibers. P2X receptor-mediated sensory
inputs can be either innocuous or nociceptive, depending on which dorsal horn regions receive these inputs. We provide a
brief review of P2X receptor-mediated purinergic sensory pathways to different regions in the dorsal horn. These P2X
purinergic pathways are identified in normal animals, which provides insights into their physiological functions. Future
studies on P2X purinergic pathways in animal models of pathological conditions may provide insights on how P2X
receptors play a role in pathological pain states.
Abbreviations: ATP – adenosine 5S-triphosphate; DH–dorsal horn; DRG–dorsal root ganglion; EPSCs–excitatory
postsynaptic currents; mEPSCs–miniature excitatory postsynaptic currents; VR1–vanilloid receptor subtype 1
P2X receptors and their expression on primary
afferent neurons
P2X receptors are cation channels on the plasma mem-
branes that open in response to the binding of extracellular
ATP. Seven P2X subunits have been identified and cloned
[1, 2]. These subunits can form a number of functional
subtypes of recombinant P2X receptors in a heterologous
expression system [1, 2]. Biophysical and pharmacological
characterization of these P2X receptor subtypes have been
extensively reviewed [1, 2]. It should be pointed out that
the two terms, P2X subunit and P2X subtype, have distinct
meanings. The former only refers to a component of a
functional P2X receptor; the later is used for a functional
P2X receptor. A functional P2X receptor can be formed
from same P2X subunits (i.e., homomeric P2X receptors)
or different subunits (i.e., heteromeric P2X receptors).
All of the seven P2X receptor subunits appear to be
expressed on primary afferent neurons in the spinal dorsal
root ganglia (DRG) and trigeminal ganglia [3, 4]. ATP
and other P2X receptor agonists can evoke membrane
currents in many primary afferent neurons. The evoked
currents show three distinct phenotypes: Fast current,
slow current, and mixed current with both fast and slow
components [5–10]. The fast current is manifested by
rapid desensitization in the range of milliseconds in the
presence of agonists. In contrast, the slow current displays
weak or little desensitization in the range of seconds in
the presence of agonists. By comparing the findings from
primary afferent neurons with those recombinant P2X
receptors, it has been suggested that homomeric P2X3
receptors (P2X3) account for fast currents, heteromeric
P2X receptors composed of P2X2 and P2X3 subunits
(P2X2+3receptors) account for slow currents, and the co-
expression of P2X3 and P2X2+3receptors account for the
mixed currents [11–16]. However, for many DRG neurons
slow currents appear to also be mediated by P2X receptor
subtypes other than P2X2+3receptors [10].
Studies have shown that P2X receptors can be involved in
both peripheral and central sensory signaling and processing
[11, 12, 17–24]. In the periphery, ATP may be released as a
result of tissue stretch, injury and inflammation, visceral
distension, or sympathetic activation [25]. ATP release can
excite afferent fibers by the activation of P2X receptors
[25–27]. Behavioral studies indicate that ATP and P2X
receptors are involved in both nociceptive and innocuous
functions [28–32]. P2X receptors are suggested to play roles
in nociception under conditions of acute tissue injury and
inflammation. Furthermore, P2X receptors have been
implicated in neuropathic pain conditions [19, 33–35]. At
central sites in the spinal cord dorsal horn, sensory impulses
can release ATP [23], which may arise from afferent central
terminals, second-order neurons, or astrocytes [36]. ATP
can also be released centrally during spinal cord tissue
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in the spinal cord. Centrally released ATP [37] may act on
the central terminals of afferent fibers, which may then
modulate or directly evoke the release of neurotransmitters
from afferent central terminals [23, 24, 38]. This action may
represent a major function of ATP and P2X receptors at the
central sites in sensory pathways. P2X receptors on afferent
central terminals have novel and important implications in
the centrally initiated sensory signals including neuropathic
pain associated with disorders in the spinal cord. Further-
more, P2X receptor-mediated modulation of transmitter
release at afferent central terminals can also be a novel
mechanism for the sensitization of sensory inputs from the
periphery [39].
P2X receptor-mediated sensory pathways to different
regions of the spinal cord dorsal horn
Studies on the nociceptive functions of P2X receptors are
still at an early stage. To understand the nociceptive
functions of P2X receptors under both physiological and
pathological conditions, it is essential to identify P2X-
mediated nociceptive pathways and to know where and
how P2X-mediated nociceptive inputs are transmitted and
processed in the spinal cord dorsal horn (DH). The dorsal
horn, comprising laminae I and II (superficial laminae), III
and IV (intermediate part), and V and VI (deep laminae), is
the primary central site for processing somatic sensory
inputs [40, 41]. Both the superficial and the deep laminae
of the DH are responsible in the reception, processing and
transmission of nociceptive information [41–46]. In con-
trast, the intermediate part of the dorsal horn is mainly
involved in processing non-nociceptive information [41].
P2X sensory pathways to the dorsal horn can be studied
on spinal cord sections by immunochemistry with P2X
antibodies and by synaptic physiology using the patch-
clamp technique. These approaches are used to determine
whether the central terminals of primary afferent fibers
express P2X receptors and, if so, what types of P2X
receptors are expressed and where these P2X-expressing
terminals are located in the dorsal horn. These approaches
for the study of P2X purinergic pathways are based on the
assumption that if a type of P2X receptors is expressed at
Figure 1. An assumption of P2X purinergic pathway to the spinal cord dorsal horn and the synaptic physiological approach for the study of P2X
purinergic pathway. A) The diagram illustrates a dorsal root ganglion with both peripheral nerve endings and central terminals. The central terminals are
within the spinal cord dorsal horn. It is proposed that the expression of a P2X receptor at the central terminal also predicts its presence in other part of the
primary afferent fibers including peripheral nerve endings. Thus, P2X purinergic pathway to the dorsal horn can be mapped by studying P2X receptors at
the central terminals through synaptic physiology or immunochemistry. B) A schematic diagram illustrates the use of synaptic physiology to study P2X
purinergic pathway to the dorsal horn using spinal cord slice preparations. Synaptic transmission between afferent central terminals and dorsal horn (DH)
neurons is recorded using patch-clamp technique. Activation of P2X receptors on the central terminals of primary afferent fibers results in the release of
glutamate, which in turn activate glutamate receptors (GluR) on dorsal horn neurons and generate excitatory postsynaptic currents (EPSCs).
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peripheral site of the afferent fiber also expresses the same
type of P2X receptors (Figure 1A). Thus, by studying P2X
receptors at the central terminals of primary afferent fibers,
one can map the sensory pathways of P2X purinergic
inputs into the spinal cord dorsal horn. These approaches
can help us understand the potential functions of different
P2X subtypes in sensory transmission. However, although
this assumption is likely to be true for most receptors, it
should be noted that membrane receptors may not always
be delivered to both ends of a primary afferent fiber.
In immunochemistry studies with P2X3 antibodies, P2X3-
expressing afferent terminals [47–49] appear to be restricted to
the inner part of lamina II (lamina IIi). Lamina distribution of
afferent fibers that express other P2X subunits remains unclear,
although there was a report that showed immunoreactivity of
P2X1 and P2X2 subunits in superfacial lamina as well [50].
Except for P2X3 subunit antibodies, it appears that antibodies
for other P2X receptor subunits have limited usefulness in the
spinal cord sections. In addition, a further limitation of
immunochemistry is that it only reveals P2X subunits rather
than functional P2X receptors [36].
Figure 2. Effects of abmeATP on the frequency of miniature excitatory postsynaptic currents recorded from lamina V dorsal horn neurons. A–B)
Spinal cord slice preparation viewed under IR-DIC microscope. Lamina regions were identified under 10 objective (A). A part of a patch electrode is
also seen in panel A. The electrode tip is inside tissue about 70 mM from the surface, and its lamina location is indicated by a box. A neuron in the box
region can be seen under 40 objective (B, center of the field). The patch electrode is to the left side. C) A trace (top) shows mEPSCs recorded from a
lamina V neuron before and following application of 100 mM abmeATP. Bottom traces show, at an expanded time scale, the mEPSCs before (left three
traces) and following (right three traces) abmeATP application. D) Histogram shows the time course and degree of the increases in mEPSC frequency
after 100 mM abmeATP. It also shows, in the same recording, 2 mM capsaicin did not have effect on mEPSCs. Modified and reprinted (with permission)
from Nakatsuka et al. [38]. Copyright by the Society for Neuroscience.
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recording technique for the study of P2X purinergic
sensory pathways (Figure 1B) provides the opportunity to
assess both function and structure in the system in several
ways. First, this approach allows one to assess functional
P2X receptors that are expressed on primary afferent
central terminals. Second, it reveals the effects of P2X
purinergic sensory inputs on dorsal horn neurons (i.e., the
secondary-order sensory neurons within the dorsal horn).
Third, it allows one to characterize neuronal circuits that
are involved in processing P2X purinergic sensory inputs
within the dorsal horn. To this end, we have applied patch-
clamp recording technique to the spinal cord slice
preparations to assess the effects of P2X receptor activation
on monosynaptic and polysynaptic transmission from
primary afferent fibers to dorsal horn neurons located in a
number of lamina regions. We have found that P2X
agonists increased monosynaptic transmission from affer-
ent central terminals to the dorsal horn neurons located in
lamina V (Figure 2) and lamina II [23, 24, 38]. The original
aim of these studies was to explore the role of presynaptic
P2X receptors, i.e., P2X receptors at the central terminal of
primary afferent fibers in modulating glutamate release
from P2X-expressing afferent central terminals. However,
based on our assumption as illustrated in Figure 1,
presynaptic P2X receptor-mediated increases of monosyn-
aptic transmission have also revealed sensory pathways
from some P2X-expressing afferent fibers to dorsal horn
neurons in these regions (also see [36]). Recordings from
lamina V neurons demonstrated that P2X receptor agonists
produced a prolonged increase of monosynaptic trans-
mission to the majority of lamina V neurons (Figure 2;
[23, 24]). This finding suggests the wide expression of P2X
receptors at the central terminals of these afferent fibers
(Figure 3). These afferent fibers have been found to be Ad
afferent fibers and insensitive to capsaicin (Figures 2 and 3),
a noxious stimulant that has been commonly used to identify
nociceptive afferent fibers. Pharmacological studies have
suggested that the P2X receptors expressed on these
capsaicin-insensitive Ad afferent terminals were not P2X3
or P2X2+3subtypes but were more likely to be P2X1+5or
P2X4+6subtypes [10, 38]. One potential function of this
P2X purinergic sensory pathway may be to transmit
sensory information of mechanical stimuli, as based on
sensory physiology of Ad-afferent fibers that innervates
lamina V of the spinal cord dorsal horn. Currently, it is
unclear whether this P2X purinergic sensory pathway is
directly involved in nociceptive transmission due to its lack
of capsaicin sensitivity. However, nociceptive afferent
fibers can also be capsaicin-insensitive. Interestingly, we
have found that this ATP-sensitive/capsaicin-insensitive
P2X purinergic pathway has convergence and temporal
summation with a capsaicin-sensitive input that is poly-
synaptically transmitted to lamina V neurons (Figure 3;
[24]). This convergence may suggest that this ATP-
sensitive/capsaicin-insensitive P2X purinergic pathway
has interaction with nociceptive input.
In contrast to lamina V, many lamina II neurons are
monosynaptically contacted by P2X3-expressing afferent
fibers ([38], Figure 3). This result is consistent with
immunochemistry of P2X3 subunit distribution in lamina
II. These P2X3-expressing afferent fibers also express VR1
receptors [47, 51] and are sensitive to capsaicin. Thus, this
P2X3 sensory pathway may be directly involved in
transmitting noxious signals. Consistent with this idea,
previous studies have shown the nociceptive function of
P2X3 [35, 52–54]. The ATP-sensitive/capsaicin-sensitive
pathway to lamina II was shown to converge to lamina V
neurons through polysynaptic transmission ([24], Figure 3).
This may mediate the spatial and temporal sensory
summation and subsequent hyperactivity in deep laminae,
a potential mechanism of hyperalgesia.
Another important region for pain transmission, process-
ing, and the development of pathological pain is lamina I
of the dorsal horn. Due to technical difficulties in
performing electrophysiological recordings in lamina I
region, there is no report on whether P2X-mediated
sensory signals are transmitted to and processed in this
important nociceptive region. Our recent experiments
performed in lamina I show that some afferent fibers
innervating lamina I neurons also express P2X receptors at
their central sites (Figure 3, unpublished result, presented
at the Purines 2004 meeting). These afferent fibers are
capsaicin-sensitive fibers, suggesting that this is a nocicep-
tive P2X purinergic pathway to the spinal cord dorsal horn.
These P2X receptors are less likely to be P2X3 containing
subtypes based on the restricted lamina IIi distribution of
P2X3-expression afferent central terminals [47, 51]. It
would be interesting to identify the P2X subtype or
subtypes and to see whether it can be a selective target
for the control of pain conditions.
Concluding remarks
The map of P2X purinergic sensory input to different
laminas of the spinal cord dorsal horn helps in understand-
ing the sensory functions of P2X receptors. Under
pathological conditions, the destination of P2X purinergic
Figure 3. P2X-purinergic sensory pathways to the dorsal horn of the
spinal cord. The schematic diagram illustrates three P2X-purinergic
sensory pathways to laminas I, II, and V of the dorsal horn. The pathway
to lamina II is the afferent fibers expressing both P2X3 and VR1 receptors.
The P2X receptor subtypes of two other pathways had pharmacological
properties distinct from P2X3 containing receptors.
14 J.G. Gu & M.W. Heftsensory input in different laminas may be altered due to an
aberrant expression of P2X receptors on primary afferent
fibers [34, 55]. This can be a potential mechanism by
which P2X receptors are involved in abnormal sensations
such as mechanical allodynia.
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